Top Australian Healthcare Stocks
Comparison Results
Name | Sector | Price | Volume | Market Cap | P/E Ratio | Dividend Yield | Analyst Consensus | Analyst Price Target | Smart Score | Article | Follow |
|---|---|---|---|---|---|---|---|---|---|---|---|
 | Healthcare | AU$137.29 | 993.64K | AU$67.55B | 34.11 | 3.07% | Moderate Buy | xxxxxxxxxxxxx | |||
 | Healthcare | AU$39.51 | 402.56K | AU$9.14B | 12.30 | 2.07% | Hold | xxxxxxxxxxxxx | |||
 | Healthcare | AU$19.72 | 1.06M | AU$9.77B | 10.64 | 5.46% | Moderate Buy | xxxxxxxxxxxxx | |||
 | Healthcare | AU$172.31 | 268.17K | AU$11.26B | 26.40 | 2.50% | Moderate Buy | xxxxxxxxxxxxx | |||
 | Healthcare | AU$132.38 | 417.23K | AU$13.26B | 33.69 | 0.49% | Strong Buy | xxxxxxxxxxxxx | |||
 | Healthcare | AU$3.54 | 1.14M | AU$1.13B | 31.27 | ― | Moderate Buy | xxxxxxxxxxxxx | |||
 | Healthcare | AU$2.02 | 1.44M | AU$390.60M | 23.92 | 6.16% | Hold | xxxxxxxxxxxxx | |||
 | Healthcare | AU$29.31 | 229.64K | AU$4.21B | 9.32 | 2.70% | Moderate Buy | xxxxxxxxxxxxx | |||
 | Healthcare | AU$15.77 | 4.03M | AU$4.96B | ― | ― | Strong Buy | xxxxxxxxxxxxx | |||
 | Healthcare | AU$0.14 | 990.17K | AU$49.98M | ― | ― | ― | xxxxxxxxxxxxx |
Top 10 Popular Investment Themes
Popular Stock Pairs
Performance Comparison
AU:CSL
CSL
139.19
-93.98
-40.31%
AU:RHC
Ramsay Health Care
39.77
7.87
24.67%
AU:SHL
Sonic Healthcare Limited
19.77
-4.30
-17.86%
AU:COH
Cochlear
172.10
-83.77
-32.74%
AU:PME
Pro Medicus Limited
126.92
-85.20
-40.17%
AU:ANN
Ansell
29.81
1.46
5.16%
AU:TLX
Telix Pharmaceuticals
14.64
-11.72
-44.46%
AU:IMU
Imugene
0.14
-0.74
-84.16%
AU:NAN
Nanosonics Limited
3.72
-1.00
-21.19%
AU:ACL
Australian Clinical Labs Ltd
2.07
-0.74
-26.33%
Healthcare Latest News
Read the latest stock news and analysis from the TipRanks news team.
Recent Analysts Ratings of Healthcare Stocks
Most Recent Earnings of Healthcare Stocks
Aug 27, 2026TBA
AU$9.14B
AU$0.68
AU$9.52B
<0.01
12.30
Aug 26, 2026TBA
AU$9.77B
AU$0.66
AU$5.54B
―
10.64
Aug 13, 2026TBA
AU$11.26B
AU$3.25
AU$1.28B
―
26.40
Aug 19, 2026TBA
AU$13.26B
AU$0.81
AU$149.09M
0.24
33.69
Aug 25, 2026TBA
AU$4.21B
AU$1.11
AU$1.49B
0.57
9.32
Aug 20, 2026TBA
AU$4.96B
AU$0.03
AU$335.71M
―
―
Aug 28, 2026TBA
AU$49.98M
―
―
―
―
Sep 1, 2026TBA
AU$1.13B
AU$0.03
AU$107.65M
1.30
31.27
Aug 26, 2026TBA
AU$390.60M
AU$0.10
AU$372.33M
―
23.92
Aug 18, 2026TBA
AU$67.55B
AU$4.00
AU$10.63B
―
34.11
Compare Stocks Side-by-SideOur stock comparison tool allows investors to compare multiple stocks simultaneously, providing comprehensive insights into key metrics, financial data, and analyst ratings. Make informed investment decisions by analyzing stocks side by side.Key Features of Our Stock Comparison
Comprehensive Analysis: Compare up to 10 stocks with detailed metrics including price, market cap, P/E ratio, dividend yield, and more.
Analyst Ratings: View consensus ratings from top Wall Street analysts and their price targets for each stock.
Performance Tracking: Analyze historical performance with interactive charts showing 3-month, 6-month, 1-year, YTD, 3-year, and 5-year returns.
Dividend Information: Evaluate dividend yield, payout ratio, and dividend growth for income-focused investors.
Earnings Data: Compare earnings per share (EPS), revenue growth, and profitability metrics across companies.
How to Use the Stock Comparison ToolSimply enter the ticker symbols of the stocks you want to compare in the search box above. You can add up to 10 stocks at once. The tool will automatically populate comparison tables with the latest data, allowing you to analyze and contrast different investment opportunities across various sectors and industries.
Popular Stock ComparisonsInvestors frequently compare stocks within the same sector to identify the best investment opportunities. Popular comparisons include tech giants like Apple (AAPL) vs. Microsoft (MSFT), semiconductor leaders Nvidia (NVDA) vs. AMD, beverage companies Coca-Cola (KO) vs. Pepsi (PEP), and electric vehicle makers Tesla (TSLA) vs. Rivian (RIVN).
Why Compare Stocks?Comparing stocks helps investors identify which companies offer the best value, growth potential, and risk-adjusted returns. By analyzing multiple stocks side by side, you can better understand relative valuations, competitive advantages, and market positioning before making investment decisions.
All Stock Comparison Categories
Healthcare - FAQ
Which Healthcare stocks have a "Strong Buy" analyst rating?
These Healthcare stocks currently have a "Strong Buy" analyst rating consensus:
Pro Medicus Limited - Strong Buy, based on 11 analyst ratings, 10 Buy, 1 Hold, and 0 Sell.
Telix Pharmaceuticals - Strong Buy, based on 9 analyst ratings, 9 Buy, 0 Hold, and 0 Sell.
Are Healthcare stocks overpriced?
CSL's stock price is currently AU$137.29, and its average 12-month price target is AU$213.55.
Ramsay Health Care's stock price is currently AU$39.51, and its average 12-month price target is AU$41.50.
Sonic Healthcare Limited's stock price is currently AU$19.72, and its average 12-month price target is AU$24.61.
Cochlear 's stock price is currently AU$172.31, and its average 12-month price target is AU$245.52.
Pro Medicus Limited's stock price is currently AU$132.38, and its average 12-month price target is AU$216.35.
Nanosonics Limited's stock price is currently AU$3.54, and its average 12-month price target is AU$4.22.
Australian Clinical Labs Ltd's stock price is currently AU$2.02, and its average 12-month price target is AU$2.33.
Ansell's stock price is currently AU$29.31, and its average 12-month price target is AU$37.59.
Telix Pharmaceuticals's stock price is currently AU$15.77, and its average 12-month price target is AU$24.52.
Imugene's stock price is currently AU$0.14, and its average 12-month price target is N/A.
Which Healthcare stocks pay dividends?
CSL does not currently pay dividends.
Ramsay Health Care does not currently pay dividends.
Sonic Healthcare Limited does not currently pay dividends.
Cochlear does not currently pay dividends.
Pro Medicus Limited does not currently pay dividends.
Nanosonics Limited does not currently pay dividends.
Australian Clinical Labs Ltd does not currently pay dividends.
Ansell does not currently pay dividends.
Telix Pharmaceuticals does not currently pay dividends.
Imugene does not currently pay dividends.